Clinical Trials
4
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Phase 1
4 (100.0%)Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine
Phase 1
Not yet recruiting
- Conditions
- Herpes Zoster
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05718037
Phase β Clinical Trial of a Candidate COVID-19 Vaccine
Phase 1
Not yet recruiting
- Conditions
- COVID-19
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05706324
- Locations
- πΈπ¬
National University Hospital, Singapore, Singapore
Phase I Clinical Trial of a Candidate HPV Vaccine
Phase 1
Not yet recruiting
- Conditions
- Human Papillomavirus Infection
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2023-01-06
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05672966
- Locations
- π¦πΊ
Paratus Clinical Research Canberra, Canberra, Australia
Phase I Clinical Trial of a Candidate PCV13 in Healthy People
Phase 1
Recruiting
- Conditions
- Pneumococcal Infections
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Wuhan BravoVax Co., Ltd.
- Target Recruit Count
- 264
- Registration Number
- NCT05602480
- Locations
- π¨π³
Xiangtan Maternal and Child Health Hospital, Xiangtan, Hunan, China
News
No news found